Literature DB >> 1638265

Fluoxetine as a treatment for emotional lability after brain injury.

R L Sloan1, K W Brown, B Pentland.   

Abstract

Emotional lability or emotionalism is a relatively common phenomenon and frequently occurs following vascular or traumatic brain injury. It is distressing and embarrassing to sufferers and their families, and often interferes with rehabilitation. At present there is no satisfactory or reliable treatment for this condition. We describe an open trial using fluoxetine, a newer antidepressant with a specific serotonergic action, in the treatment of emotional lability due to brain injury. Six consecutive cases of emotional lability attending a rehabilitation unit were studied (five cases of cerebrovascular accident and one of traumatic brain injury). Response to treatment was measured using a modification of the scale described by Lawson and MacLeod [1]. All showed a marked improvement within one week of commencing fluoxetine and the drug was well tolerated with no reported side-effects. The speed of onset and degree of improvement suggest that fluoxetine may be a useful agent in the treatment of emotional lability due to brain injury. Our observations indicate that further investigation of the role of fluoxetine in the treatment of emotional lability is warranted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638265     DOI: 10.3109/02699059209034945

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  15 in total

1.  Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

Authors:  Roy E Strowd; Michael S Cartwright; Michael S Okun; Ihtsham Haq; Mustafa S Siddiqui
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

Review 2.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  A self report measure of affective lability.

Authors:  S R Moore; L S Gresham; M B Bromberg; E J Kasarkis; R A Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 4.  Poststroke depression: prevalence, course, and associated factors.

Authors:  S G Hosking; N V Marsh; P J Friedman
Journal:  Neuropsychol Rev       Date:  1996-09       Impact factor: 7.444

Review 5.  Treatment of uncontrolled crying after stroke.

Authors:  G Andersen
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 6.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 7.  Common psychiatric syndromes and pharmacologic treatments of traumatic brain injury.

Authors:  L A Labbate; D L Warden
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

8.  Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Jennie L Ponsford; Luke A Perry; Mahesh Jayaram; Rachel Batty; Malcolm Hopwood
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

9.  Neuropsychiatric Aspects of Traumatic Brain Injury.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

10.  Pharmaceutical interventions for emotionalism after stroke.

Authors:  Sabine Allida; Kulsum Patel; Allan House; Maree L Hackett
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.